ALTRINSIC GLOBAL ADVISORS LLC - DICERNA PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
ALTRINSIC GLOBAL ADVISORS LLC ownership history of DICERNA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2020$540,000
-58.2%
30,000
-66.7%
0.02%
-60.7%
Q3 2019$1,292,000
-8.9%
90,0000.0%0.06%
-15.2%
Q2 2019$1,418,000
+7.5%
90,0000.0%0.07%
+8.2%
Q1 2019$1,319,00090,0000.06%
Other shareholders
DICERNA PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 1,355,392$29,859,0006.21%
Bain Capital Life Sciences Investors, LLC 3,080,237$67,858,0004.26%
DAFNA Capital Management LLC 587,756$12,948,0003.85%
SILVERARC CAPITAL MANAGEMENT, LLC 227,388$5,009,0002.91%
RTW INVESTMENTS, LP 7,253,857$159,802,0002.68%
Parkman Healthcare Partners LLC 331,513$7,303,0001.87%
Evolutionary Tree Capital Management, LLC 60,864$1,341,0001.02%
Eagle Health Investments LP 69,000$1,520,0000.97%
Woodline Partners LP 1,358,796$29,934,0000.79%
Affinity Asset Advisors, LLC 40,000$881,0000.47%
View complete list of DICERNA PHARMACEUTICALS INC shareholders